The DOI matches its Crossref record; 14 of the 18 references it cites were found in a registry or an index.
The use of ceftaroline fosamil in methicillin-resistant Staphylococcus aureus endocarditis and deep-seated MRSA infections: a retrospective case series of 10 patients
Abstract
There are many limitations to the current antibiotics used for the treatment of severe methicillin-resistant Staphylococcus aureus (MRSA) infections. Ceftaroline is a new fifth-generation cephalosporin approved for the treatment of skin and soft tissue infections caused by MRSA and community-acquired pneumonia. We propose that ceftaroline can also be used successfully in more severe MRSA infections, including endocarditis. We conducted a retrospective chart review in a university-affiliated Department of Veterans Affairs hospital in San Diego, California (USA) of ten inpatients treated with ceftaroline for severe MRSA infection, including five cases of probable endocarditis (including two endocardial pacemaker infections), one case of pyomyositis with possible endocarditis, two cases of pneumonia (including one case of empyema), two cases of septic arthritis (including one case of prosthetic joint infection), and two cases of osteomyelitis. Seven of the 10 patients achieved microbiological cure. Six of the 10 patients achieved clinical cure. Seven patients were discharged from the hospital. Three patients were placed on comfort care and expired in the hospital; one achieved microbiological cure before death, and two remained bacteremic at time of death. In most patients, ceftaroline was effective for treatment of MRSA bacteremia and other severe MRSA infections. Adverse effects seen included rash, eosinophilia, pruritus, and Clostridium difficile infection. Ceftaroline can be…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Cosgrove, S. E., Sakoulas, G., Perencevich, E. N., Schwaber, M. J., Karchmer, A. W., & Carmeli, Y. (2003) · Clinical Infectious Diseases · doi:10.1086/345476 · Cited by 1,964
Daptomycin versus Standard Therapy for Bacteremia and Endocarditis Caused by Staphylococcus aureus
Fowler, V. G., Boucher, H. W., Corey, G. R., Abrutyn, E., Karchmer, A. W., Rupp, M. E., Levine, D. P., Chambers, H. F., Tally, F. P., Vigliani, G. A., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa053783 · Cited by 1,459
Chang, F.-Y., Peacock, J. E., Musher, D. M., Triplett, P., MacDonald, B. B., Mylotte, J. M., O’Donnell, A., Wagener, M. M., & Yu, V. L. (2003) · Medicine · doi:10.1097/01.md.0000091184.93122.09 · Cited by 530
Stryjewski, M. E., Szczech, L. A., Benjamin, D. K., Inrig, J. K., Kanafani, Z. A., Engemann, J. J., Chu, V. H., Joyce, M. J., Reller, L. B., Corey, G. R., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/510386 · Cited by 348
Risk of death from methicillin‐resistant Staphylococcus aureus bacteraemia: a meta‐analysis
Whitby, M., McLaws, M., & Berry, G. (2001) · Medical Journal of Australia · doi:10.5694/j.1326-5377.2001.tb143562.x · Cited by 296
Wilcox, M. H., Corey, G. R., Talbot, G. H., Thye, D., Friedland, D., Baculik, T., on behalf of the CANVAS 2 investigators, Manos, P., Lee, P., Bush, L., et al. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq255 · Cited by 216
File, T. M., Low, D. E., Eckburg, P. B., Talbot, G. H., Friedland, H. D., Lee, J., Llorens, L., Critchley, I. A., Thye, D. A., on behalf of the FOCUS 1 investigators, et al. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr096 · Cited by 197
Low, D. E., File, T. M., Eckburg, P. B., Talbot, G. H., David Friedland, H., Lee, J., Llorens, L., Critchley, I. A., Thye, D. A., on behalf of the FOCUS 2 investigators, et al. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr097 · Cited by 185
Kosowska-Shick, K., McGhee, P. L., & Appelbaum, P. C. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00019-10 · Cited by 179
Corey, G. R., Wilcox, M. H., Talbot, G. H., Thye, D., Friedland, D., Baculik, T., on behalf of the CANVAS 1 investigators, Mehra, P., Alpert, M., Baird, I., et al. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq254 · Cited by 165
Cited by
Baddour, L. M., Wilson, W. R., Bayer, A. S., Fowler, V. G., Tleyjeh, I. M., Rybak, M. J., Barsic, B., Lockhart, P. B., Gewitz, M. H., Levison, M. E., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000296 · Cited by 3,232
Sandoe, J. A. T., Barlow, G., Chambers, J. B., Gammage, M., Guleri, A., Howard, P., Olson, E., Perry, J. D., Prendergast, B. D., Spry, M. J., et al. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku383 · Cited by 403
Management Considerations in Infective Endocarditis: A Review
Wang, A., Gaca, J. G., & Chu, V. H. (2018) · JAMA · doi:10.1001/jama.2018.7596 · Cited by 368
Treatment of Staphylococcus aureus Infections
David, M. Z., & Daum, R. S. (2017) · Current Topics in Microbiology and Immunology · doi:10.1007/82_2017_42 · Cited by 185
Clinical Management of Septic Arthritis
Sharff, K. A., Richards, E. P., & Townes, J. M. (2013) · Current Rheumatology Reports · doi:10.1007/s11926-013-0332-4 · Cited by 149
Metadata
- Authors
- Lin, J. C., Fierer, J., Aung, G., Johns, S., Thomas, A., Jahng, M., Fierer, J., & Fierer, J.
- Affiliations
- University of California San Diego (US)
- VA San Diego Healthcare System (US)
- University of the Pacific (US)
- Raymond G. Murphy VA Medical Center (US)
- Corresponding author
- Lin, Jennifer C.
- ORCID
- Johns, Scott
- Venue
- Journal of Infection and Chemotherapy
- Publisher
- Elsevier BV
- Published
- 2013
- Volume
- 19
- Issue
- 1
- Pages
- 42-49
- ISSN
- 1341-321X (ISSN-L)
- OpenAlex
- W2143371514
- Semantic Scholar
- 56adb47bac20ce91d08b36f89ce469d508e3ae3e
- Cited by
- 109
- References
- 18
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 3 · 2023: 4 · 2022: 2 · 2021: 3 · 2020: 4 · 2019: 9 · 2018: 6 · 2017: 17 · 2016: 12 · 2015: 15 · 2014: 22 · 2013: 9
- FWCI
- 10.16
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- Locations
- Journal of Infection and Chemotherapy (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Allergy and Infectious Diseases (T32AI007036)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Infective Endocarditis Diagnosis and Management
- Health Sciences › Medicine › Infectious Diseases › Otolaryngology and Infectious Diseases
- Keywords
- ceftaroline fosamil, methicillin-resistant Staphylococcus aureus, MRSA endocarditis, MRSA bacteremia, pyomyositis, empyema, septic arthritis, periprosthetic joint infection, osteomyelitis, Clostridium difficile infection, adverse drug reactions, veterans
- MeSH terms
- Ceftaroline, Adult, Aged, Aged, 80 and over, Anti-Bacterial Agents, Arthritis, Infectious, Cephalosporins, Endocarditis, Bacterial, Female, Humans, Male, Middle Aged, Osteomyelitis, Pneumonia, Staphylococcal, Prodrugs, Retrospective Studies, Staphylococcal Infections, Bacteremia, Treatment Outcome, Methicillin-Resistant Staphylococcus aureus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The use of ceftaroline fosamil in methicillin-resistant Staphylococcus aureus endocarditis and deep-seated MRSA infections: a retrospective case series of 10 patients. https://app.cochat.ai/papers/10.1007/s10156-012-0449-9
- The paper
- Lin, J. C., Fierer, J., Aung, G., Johns, S., Thomas, A., Jahng, M., Fierer, J., & Fierer, J. (2013). The use of ceftaroline fosamil in methicillin-resistant Staphylococcus aureus endocarditis and deep-seated MRSA infections: a retrospective case series of 10 patients. Journal of Infection and Chemotherapy. https://doi.org/10.1007/s10156-012-0449-9
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.